Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (252)	1/30/2003 1:07:48 PM
From: Jibacoa	Read Replies (2) \| Respond to of 3722

NTII Is up more than 11% today on volume of 62.2K(still not up to its daily average.) The stock has more than doubled since its October Ls at the 2.32 level and now seems headed to test its January 22 H at 8.<g> Memantine has been approved in Europe for the treatment of Alzheimer's and the company cut its loss on its last Q to $0. It still has about $1.4M in cash (about $0.08/share <g>) siliconinvestor.com Of course, the stock still will face some resistance from the 8.30 level up ti its August 2000 H at 11.12 <g> siliconinvestor.com Bernard